DEFC14A: Politan Capital Launches Proxy Fight at Masimo, Nominates Two Independent Directors

Politan Capital Management is soliciting proxies to elect two independent director candidates, William Jellison and Darlene Solomon, to Masimo Corporation's board at the 2024 annual meeting, aiming to improve corporate governance and shareholder value.

Summary

• Politan Capital Management is seeking to elect William Jellison and Darlene Solomon as Class II directors at Masimo's 2024 annual meeting.
• Politan believes the current board has undermined attempts to improve corporate governance, leading to worsening financial metrics and increased risks.
• Politan nominated Michelle Brennan and Quentin Koffey in 2023, who were elected, but Politan feels their efforts have been rebuffed.
• The proxy statement also includes proposals to ratify Grant Thornton LLP as the company's auditor, an advisory vote on executive compensation, and a proposal to repeal bylaw amendments adopted by the board without stockholder approval after April 20, 2023.
• Politan urges stockholders to vote for its nominees and against certain company proposals, citing concerns about corporate governance and the handling of a potential separation of the consumer business.
• As of the date hereof, the members of the Politan Parties in this solicitation collectively own an aggregate of 4,713,518 shares of Common Stock.

Sentiment

Score: 3

Explanation: The document reflects a negative sentiment due to the ongoing proxy fight, criticisms of the current board, and concerns about corporate governance and financial performance.

Positives

• Politan's nominees are described as highly qualified and independent, with relevant operational, industry, and financial expertise.
• The proposed repeal of bylaw amendments aims to ensure stockholder rights and prevent board overreach.
• Politan supports a strategic review of the separation of the consumer business, which could unlock value for shareholders.
• The election of Politan's nominees could lead to improved corporate governance and oversight of management decisions.

Negatives

• Politan believes the current board has undermined attempts to improve corporate governance.
• The company's financial metrics and total shareholder return have worsened, according to Politan.
• Politan alleges that the board has withheld information from the 2023 Newly-Elected Directors and excluded them from meetings.
• Politan expresses concerns about the potential for Mr. Kiani to push through a separation of the consumer business that benefits him personally at the expense of shareholders.

Risks

• There is no assurance that the company's other directors will serve if the Politan nominees are elected.
• The company may take actions prior to the 2024 Annual Meeting that could negatively impact shareholder election rights.
• The separation of the consumer business could be structured in a way that benefits Mr. Kiani at the expense of shareholders.
• The company is facing a civil investigative demand from the Department of Justice and a subpoena from the Securities and Exchange Commission.

Future Outlook

The document focuses on the upcoming 2024 Annual Meeting and the election of directors, with the potential separation of the consumer business as a key strategic consideration.

Management Comments

• Mr. Kiani stated the companyhas been approached by a potential partnera joint venture would likely be much faster.
• Mr. Kiani said: We may have been able to even do a JV before the shareholder meeting because the JV wants to get it done by June 25, but right now, the activist is pushing back, threatening litigation.

Industry Context

The proxy fight highlights the increasing trend of activist investors seeking to influence corporate governance and strategy at publicly traded companies, particularly in the healthcare and technology sectors.

Comparison to Industry Standards

• The document does not provide specific comparisons to industry standards.
• However, it implies that Masimo's corporate governance practices are below par compared to best-in-class standards, as Politan seeks to implement improvements.
• The document references the company's stock price decline and financial performance, suggesting underperformance relative to peers.

Legal Proceedings

• The Company was served with a civil investigative demand from the Department of Justice and a subpoena from the Securities and Exchange Commission (the SEC) on March 25, 2024 and March 26, 2024, respectively.

Stakeholder Impact

• The outcome of the proxy contest could significantly impact shareholders, employees, and other stakeholders.
• Improved corporate governance and strategic decisions could lead to enhanced shareholder value.
• The potential separation of the consumer business could have implications for employees and customers of both entities.

Next Steps

• Stockholders are urged to vote on the WHITE universal proxy card.
• The 2024 Annual Meeting will be held on July 25, 2024.
• The outcome of the proxy contest will determine the composition of the board and the direction of the company's strategy.

Key Dates

Keywords

proxy solicitation, director nominees, corporate governance, shareholder value, Politan Capital, Masimo, board of directors, annual meeting